Work

A phase 1 study of selinexor (S) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced ovarian (OC) or endometrial cancers (EC)

FWCI: 0.271
Cites:
Cited by: 1
Related to: 10